Stereotaxis CEO to Present Surgical Robotics Leadership at TD Cowen Healthcare Conference
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that David Fischel,...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that David Fischel,...
By Shruti KharbandaRobotics and AI is assuredly transforming healthcare.The Global Medical Robots market is valued at $16 billion in 2024...